Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Fulgent Diagnostics

Fulgent Diagnostics?uq=PEM9b6PF
2011 FOUNDED
PUBLIC STATUS
91-100 EMPLOYEES
FLGT STOCK SYMBOL
Description

Provider of cancer drug research services. The company offers cancer drug research, personalized cancer treatments, genetic testing and genetic diagnostic services.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Other Healthcare Services
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Stock Exchange
NAS
Primary Office
  • 4978 Santa Anita Avenue
  • Suite 205
  • Temple City, CA 91780
  • United States

+1 (626) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Fulgent Diagnostics’s full profile, request a free trial.

Fulgent Diagnostics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Fulgent Diagnostics‘s full profile, request access.

Request full access to PitchBook

Fulgent Diagnostics Executive Team (3)

Name Title Board
Seat
Contact
Info
Ming Hsieh Co-Founder, Chairman & Chief Executive Officer
Paul Kim Chief Financial Officer
Harry Gao Ph.D Chief Scientific Officer & Lab Director

Fulgent Diagnostics Board Members (1)

Name Representing Role Since Contact
Info
0000 00000 Fulgent Diagnostics Co-Founder, Chairman & Chief Executive Officer 000 0000